David Schlessinger

Title: David Schlessinger: Innovator in Molecular Cloning

Introduction

David Schlessinger is a prominent inventor based in University City, MO (US). He has made significant contributions to the field of molecular biology, particularly in the area of genetic research. With a total of 2 patents, Schlessinger's work has advanced our understanding of genetic disorders.

Latest Patents

Schlessinger's latest patents focus on the molecular cloning of the anhidrotic ectodermal dysplasia gene. The first patent relates to various yeast artificial chromosomes (YACs) that contain all or a portion of the human EDA gene responsible for anhidrotic ectodermal dysplasia. This invention includes probes specific for the human EDA gene and methods for diagnosing EDA gene-related disorders. The second patent also addresses the molecular cloning of the EDA gene, further enhancing diagnostic capabilities for related conditions.

Career Highlights

David Schlessinger is affiliated with Washington University, where he has conducted extensive research in genetics. His work has not only contributed to academic knowledge but has also paved the way for potential therapeutic applications in treating genetic disorders.

Collaborations

Some of Schlessinger's notable coworkers include Juha Kere and Albert De La Chapelle. Their collaborative efforts have enriched the research environment and fostered advancements in genetic studies.

Conclusion

David Schlessinger's innovative work in molecular cloning and genetic research has made a lasting impact on the field. His contributions continue to influence the understanding and diagnosis of genetic disorders.